Curable compositions and membranes

US9487418B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9487418-B2
Application numberUS-201514979740-A
CountryUS
Kind codeB2
Filing dateDec 28, 2015
Priority dateDec 16, 2009
Publication dateNov 8, 2016
Grant dateNov 8, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 15 to 45 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; wherein the molar ratio of (i):(ii) is 0.1 to 1.5. The compositions are useful for preparing ion exchange membranes.

First claim

Opening claim text (preview).

The invention claimed is: 1. A device selected from the group consisting of an electrodialysis or reverse electrodialysis unit, an electrodeionization module and a flow through capacitor, the device comprising a membrane obtained by a process comprising the following steps: applying a curable composition to a support; and curing the composition to form a membrane; wherein the curable composition comprises: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 15 to 45 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; wherein the molar ratio of (i):(ii) is 0.1 to 1.5. 2. The device according to claim 1 wherein the device is an electrodialysis or reverse electrodialysis unit. 3. The device according to claim 2 which further comprises at least one anode and at least one cathode. 4. The device according to claim 3 which further comprises an inlet for providing a flow of relatively salty water along a first side of the membrane and an inlet for providing a less salty flow water along a second side of the membrane such that ions pass from the first side to the second side of the membrane. 5. The device according to claim 1 wherein the device is a flow through capacitor. 6. The device according to claim 5 which further comprises at least one anode and at least one cathode. 7. The device according to claim 1 wherein the device is an electrodeionization module. 8. The device according to claim 7 which further comprises at least one anode and at least one cathode. 9. The device according to claim 1 wherein the curable composition comprises 7.47 to 43.33 wt % crosslinker comprising at least two acrylamide groups. 10. The device according to claim 1 wherein the curable composition comprises: (i) 8 to 16 wt % crosslinker comprising at least two acrylamide groups; (ii) 40 to 60 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 22 to 40 wt % solvent; and (iv) 0.01 to 2 wt % of photoinitiator; wherein the molar ratio of (i):(ii) is 0.1 to 1.0. 11. The device according to claim 10 wherein the device is an electrodialysis or reverse electrodialysis unit. 12. The device according to claim 11 which further comprises at least one anode and at least one cathode. 13. The device according to claim 12 which further comprises an inlet for providing a flow of relatively salty water along a first side of the membrane and an inlet for providing a less salty flow water along a second side of the membrane such that ions pass from the first side to the second side of the membrane. 14. The device according to claim 10 wherein the device is a flow through capacitor. 15. The device according to claim 14 which further comprises at least one anode and at least one cathode. 16. The device according to claim 10 wherein the device is an electrodeionization module. 17. The device according to claim 16 which further comprises at least one anode and at least one cathode.

Assignees

Inventors

Classifications

  • Dialytic cells or batteries; Reverse electrodialysis cells or batteries · CPC title

  • Fuel cells with aqueous electrolytes · CPC title

  • Electrolytic cell with membranes or diaphragms · CPC title

  • characterised by the use of ion-exchange material in the form of ribbons, filaments, fibres or sheets, e.g. membranes (electrodialysis or electro-osmosis B01D61/42) · CPC title

  • electrodialysis · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9487418B2 cover?
A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 15 to 45 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; wherein the molar ratio of (i):(ii) is 0.1 to 1.5. The compositions are useful …
Who is the assignee on this patent?
Fujifilm Mfg Europe Bv
What technology area does this patent fall under?
Primary CPC classification C02F1/4691. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).